• Home
  • Cooley team
  • Resources
  • Cooley.com
Explore Close
Menu Close

Categories

ExperienceInsightRegulatoryMarket UpdatesDeal TermsDeal LitigationEventsFiduciary DutiesCrossborderSPACsExitsFirm NewsDue DiligenceLitigationSPACs

Tags

AntitrustDelawareTrendsJudicialPrivate EquityDeal TermsLitigationRegulatoryCrossborderLife SciencesActivismTechEarnoutsFiduciary DutiesSECAppraisalCOVID-19United KingdomCFIUSSPACs

Archives

June 2026 May 2026 April 2026 March 2026 February 2026 January 2026
  • Home
  • Cooley team
  • Resources
  • Cooley.com
  • Insight
  • Events

Cooley M&A

Key deals, decisions + trends

  • Insight
  • Events
Close
Experience

Observe Announces Acquisition by Snowflake

bwoodworth on March 9, 2026
    SHARE

Cooley advised Observe, a top artificial intelligence-powered observability platform, on its definitive agreement to be acquired by Snowflake, the AI data cloud company.

Observe Announces Acquisition by Snowflake

Related

  • GPTZero to be Acquired by Superhuman In "Experience"
  • First Street Acquired by MSCI In "Experience"
  • CRED Receives Significant Investment From Meta In "Experience"

    • Cooley has handled 1,600+ M&A transactions for an aggregate value of $750+ billion since 2021, making our practice one of the most active in the world. Learn more

    Loading

    By signing up for Cooley blog/marketing messages, we will only process your personal information for the purpose of sending you marketing emails in accordance with our Privacy Policy. We do not sell your information or share it with any third-parties other than those necessary for this purpose. You can unsubscribe by clicking the unsubscribe link in any email we send you. You may have other rights with respect to your information which are detailed in our PrivacyPolicy, / Cookies Policy.

    Recent M&A transactions

    • GPTZero to be Acquired by Superhuman
    • First Street Acquired by MSCI
    • CRED Receives Significant Investment From Meta
    • Fin to be Acquired by Salesforce for Approximately $3.6 Billion
    • Cooley Advises ZincFive on DeSPAC Transaction With Spark I Acquisition Corp
    • Avenzo Therapeutics to be Acquired by Rallybio
    • Curevo Vaccine to be Acquired by Eli Lilly for up to $1.5 Billion
    • Vaccine Company to be Acquired by Eli Lilly for up to $1.5 Billion
    • Engage Bio Acquired by Eli Lilly for up to $202 Million
    • Orphai Therapeutics Sale to Quince Therapeutics

    View more transactions

    Recent posts

    • Navigating M&A in Today’s Exit Market for Funds
    • Coordinating HawkEye’s Acquisition, Financings and IPO at Orbit Speed
    • SEC Exemptive Order Halves Minimum Tender Offer Period for Negotiated All-Cash Transactions
    • Cooley Market Talks – AI and the New Capital Dynamic: IPOs, M&A and What Comes Next
    • Yes, Your CEO’s AI Prompts May Be Discoverable (and Can Be Problematic)

    Disclaimer

    This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may hve been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.

    Previous
    Manus Joins Meta for Next Era of Innovation
    March 9, 2026
    Next
    GSK Agrees to Acquire RAPT Therapeutics for $2.2 Billion
    March 9, 2026

    Cooley M&A

    Cooley has handled 1,600+ M&A transactions for an aggregate value of $750+ billion since 2021, making our practice one of the most active in the world. Learn more ›

    Recent

    • Navigating M&A in Today’s Exit Market for Funds
    • Coordinating HawkEye’s Acquisition, Financings and IPO at Orbit Speed
    • SEC Exemptive Order Halves Minimum Tender Offer Period for Negotiated All-Cash Transactions
    • Cooley Market Talks – AI and the New Capital Dynamic: IPOs, M&A and What Comes Next
    • Yes, Your CEO’s AI Prompts May Be Discoverable (and Can Be Problematic)

    Categories

    • Crossborder
    • Deal Litigation
    • Deal Terms
    • Due Diligence
    • Events
    • Exits
    • Experience
    • Fiduciary Duties
    • Firm News
    • Insight
    • Litigation
    • Market Updates
    • Regulatory
    • SPACs
    • SPACs